Walter Hinderer
7Patents
3h-index
6Co-inventors
50Inventor score
Filing activity: Jul 25, 1995 → Jan 9, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6120989A | Isolated human cytomegalovirus polypeptides and uses thereof | Emerging Cross-Sectional Technologies | 30 | Expired |
| US8207112B2 | Liquid formulation of G-CSF conjugate | Human Necessities | 21 | Active |
| US8703123B2 | Method for obtaining biologically active recombinant human G-CSF | Human Necessities | 4 | Active |
| US8562967B2 | Stable liquid formulations of G-CSF | Human Necessities | 1 | Active |
| US8946161B2 | Method of treatment using stable liquid formulation of G-CSF | Human Necessities | 1 | Active |
| US9468685B2 | Methods of preparing a liquid formulation of G-CSF | Human Necessities | 0 | Active |
| US8546328B2 | Liquid formulation of G-CSF conjugate | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.